Skip to main content

Table 7 Predicted interactions found from biclusters constructed using rows as human proteins and columns as viral proteins (Sl. No. 1 to 10) and rows as viral proteins and columns as human proteins(Sl. No. 11 to 24)

From: Incorporating the type and direction information in predicting novel regulatory interactions between HIV-1 and human proteins using a biclustering approach

Sl. No.

HIV-protein

Human protein

Interaction types

Pubmed id

1

env_gp160

CCL4

Inhibited by

21118814

2

env_gp160

CCL5

Inhibited by

21118814

3

env_gp160

HDAC6

Inhibited by

16148047

4

Rev

IPO7

Imported by

16704975

5

capsid

IPO7

Imported by

20147401

6

Rev

CD4

Inhibited by

8573391

7

matrix

NFKBIA

inhibited by

10722660

8

Capsid

APOBEC3G

Interacts with

17065315

9

Vif

TP53

Interacts with

21071676

10

RT

CD4

Interacts with

22426469

11

Vif

MAPK3

Phosphorylated by

10074203

12

Vif

UBB

Ubiquitinated by

15781449

13

Vif

UBD

Ubiquitinated by

18596088

14

Vif

MAPK1

Ubiquitinated by

10074203

15

Gag_Pr55

IFNA16

Inhibited by

11197304

16

Gag_Pr55

IFNA7

Inhibited by

8553538

17

Tat

CD4

Interacts with

12457987

18

Tat

PRKCQ

Interacts with

9446795

19

Tat

LCK

Interacts with

18854243

20

p6

MAPK3

Phosphorylated by

11773377

21

p6

MAPK1

Phosphorylated by

15155723

22

Gag_Pr55

IFNA2

Inhibited by

8553538

23

env_gp160

TP53

Interacts with

19023333

24

Nef

CD28

Interacts with

21819585

  1. Here the direction of the interactions are taken from human to viral proteins.